Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma

  • Srividya Kotapati, Ying Zhang, T. Kim Le, James Shaw
  • ClinicoEconomics and Outcomes Research, July 2015, Dove Medical Press
  • DOI: 10.2147/ceor.s78704

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ceor.s78704

The following have contributed to this page: Ms Ying Zhang

Contributors